Mayne Pharma Group Limited (ASX:MYX)

Mayne Pharma Group Statistics

Total Valuation

ASX:MYX has a market cap or net worth of AUD 588.22 million. The enterprise value is 503.17 million.

Market Cap	588.22M
Enterprise Value	503.17M

Important Dates

The next estimated earnings date is Tuesday, May 27, 2025.

Earnings Date	May 27, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:MYX has 81.25 million shares outstanding. The number of shares has decreased by -3.28% in one year.

Current Share Class	n/a
Shares Outstanding	81.25M
Shares Change (YoY)	-3.28%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	8.68%
Owned by Institutions (%)	35.00%
Float	66.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.38
PB Ratio	1.32
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.70, with an EV/FCF ratio of -44.70.

EV / Earnings	-3.89
EV / Sales	1.22
EV / EBITDA	9.70
EV / EBIT	n/a
EV / FCF	-44.70

Financial Position

The company has a current ratio of 1.40, with a Debt / Equity ratio of 0.09.

Current Ratio	1.40
Quick Ratio	1.10
Debt / Equity	0.09
Debt / EBITDA	0.77
Debt / FCF	-3.54
Interest Coverage	-2.27

Financial Efficiency

Return on equity (ROE) is -23.75% and return on invested capital (ROIC) is -1.29%.

Return on Equity (ROE)	-23.75%
Return on Assets (ROA)	-0.61%
Return on Invested Capital (ROIC)	-1.29%
Return on Capital Employed (ROCE)	-1.34%
Revenue Per Employee	427,639
Profits Per Employee	-133,636
Employee Count	967
Asset Turnover	0.36
Inventory Turnover	2.22

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.28% in the last 52 weeks. The beta is 1.15, so ASX:MYX's price volatility has been higher than the market average.

Beta (5Y)	1.15
52-Week Price Change	+0.28%
50-Day Moving Average	6.12
200-Day Moving Average	4.97
Relative Strength Index (RSI)	75.02
Average Volume (20 Days)	790,262

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:MYX had revenue of AUD 413.53 million and -129.23 million in losses. Loss per share was -1.64.

Revenue	413.53M
Gross Profit	243.85M
Operating Income	-11.07M
Pretax Income	-129.94M
Net Income	-129.23M
EBITDA	48.11M
EBIT	-11.07M
Loss Per Share	-1.64

Balance Sheet

The company has 124.91 million in cash and 39.87 million in debt, giving a net cash position of 85.05 million or 1.05 per share.

Cash & Cash Equivalents	124.91M
Total Debt	39.87M
Net Cash	85.05M
Net Cash Per Share	1.05
Equity (Book Value)	446.20M
Book Value Per Share	5.49
Working Capital	123.63M

Cash Flow

In the last 12 months, operating cash flow was 391,000 and capital expenditures -11.65 million, giving a free cash flow of -11.26 million.

Operating Cash Flow	391,000
Capital Expenditures	-11.65M
Free Cash Flow	-11.26M
FCF Per Share	-0.14

Margins

Gross margin is 58.97%, with operating and profit margins of -2.68% and -31.25%.

Gross Margin	58.97%
Operating Margin	-2.68%
Pretax Margin	-31.42%
Profit Margin	-31.25%
EBITDA Margin	11.63%
EBIT Margin	-2.68%
FCF Margin	n/a

Dividends & Yields

ASX:MYX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	3.28%
Shareholder Yield	3.28%
Earnings Yield	-21.97%
FCF Yield	-1.91%

Stock Splits

The last stock split was on January 18, 2023. It was a reverse split with a ratio of 0.05.

Last Split Date	Jan 18, 2023
Split Type	Reverse
Split Ratio	0.05

Scores

ASX:MYX has an Altman Z-Score of -0.36. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.36
Piotroski F-Score	n/a